Published in Hepatitis Weekly, February 9th, 2004
"The prognosis of HIV infection has been modified by antiretroviral therapy," scientists in France explained. "However, the morbidity and the mortality of HCV co-infection are increased and may be a major problem of health service."
"Up to now co-infected patients are excluded" from liver transplantation "due to complexity the ethical aspect, the immunodeficiency and the co-infection," noted D. Vittecoq and colleagues at Paul Brousse Hospital in Villejuif, who conducted a study to "estimate the feasibility in this population."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.